{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:43:09Z","timestamp":1789062189248,"version":"build-2803163510"},"reference-count":251,"publisher":"OAE Publishing Inc.","content-domain":{"domain":["oaepublish.com"],"crossmark-restriction":false},"short-container-title":["Cancer Drug Resist"],"abstract":"<jats:p>Decades ago, the viral myeloblastosis oncogene v -myb  was identified as a gene responsible for the development of avian leukemia. However, the relevance of MYB proteins for human cancer diseases, in particular for solid tumors, remained basically unrecognized for a very long time. The human family of MYB transcription factors comprises MYB (c-MYB), MYBL2 (b-MYB), and MYBL1 (a-MYB), which are overexpressed in several cancers and are associated with cancer progression and resistance to anticancer drugs. In addition to overexpression, the presence of activated MYB-fusion proteins as tumor drivers was described in certain cancers. The identification of anticancer drug resistance mediated by MYB proteins and their underlying mechanisms are of great importance in understanding failures of current therapies and establishing new and more efficient therapy regimens. In addition, new drug candidates targeting MYB transcription factor activity and signaling have emerged as a promising class of potential anticancer therapeutics that could tackle MYB-dependent drug-resistant cancers in a more selective way. This review describes the correlation of MYB transcription factors with the formation and persistence of cancer resistance to various approved and investigational anticancer drugs.<\/jats:p>","DOI":"10.20517\/cdr.2023.158","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T05:25:00Z","timestamp":1714454700000},"update-policy":"https:\/\/doi.org\/10.20517\/oae.crossmark.policy","source":"Crossref","is-referenced-by-count":6,"title":["Emerging role of MYB transcription factors in cancer drug resistance"],"prefix":"10.20517","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7305-346X","authenticated-orcid":true,"given":"Bernhard","family":"Biersack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"H\u00f6pfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8410","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2023.86"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0196-7"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00411-8"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-00975-3"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2174\/1874467207666140307124241"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082296"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2021.55"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2022.127"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.11.022"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-021-00309-y"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-023-10153-8"},{"key":"B12","unstructured":"Nakagoshi H, Kanei-Ishii C, Sawazaki T, Mizuguchi G, Ishii S. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. Oncogene 1992; 1233-40"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.9.5120"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(83)90416-6"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1242\/bio.20123152"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.2001.0404"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.14.6428"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/335835a0"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-30"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers6042049"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202726"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.12427"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202255643"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175593"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2012.00035"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12499"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010254"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.2017630"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2008.118"},{"key":"B30","unstructured":"Sahara S, Herzog AE, N\u00f6r JE. Systemic therapies for salivary gland adenoid cystic carcinoma. Am J Cancer Res 2021; 4092-110"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-07-6611"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-99-2196-6_2-1"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1730-1"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-2976-z"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2020.24"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2021.59"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3892\/or.8.4.807"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92352-3"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28715"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203344"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0966-2"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.14715\/cmb\/2023.69.9.20"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2021.01.002"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63396-8"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2021.03.001"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-00879-9"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2018.10.012"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1515\/med-2023-0757"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-00881-1"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2018.08.042"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.mcr-16-0323-t"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.119"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110412"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-021-02979-4"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2016.04.007"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2023.101205"},{"key":"B57","unstructured":"Melani C, Rivoltini L, Parmiani G, Calabretta B, Colombo MP. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb. Cancer Res 1991; 2897-901"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23283"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0656-9"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-021-10145-4"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.430"},{"key":"B62","unstructured":"Grassilli E, Salomoni P, Perrotti D, Franceschi C, Calabretta B. Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction. Cancer Res 1999; 2451-6"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1080\/07357907.2018.1533965"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210568"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.17179\/excli2015-561"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2019.114"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m109.089045"},{"key":"B68","unstructured":"Levenson VV, Davidovich IA, Roninson IB. Pleiotropic resistance to DNA-interactive drugs is associated with increased expression of genes involved in DNA replication, repair, and stress response. Cancer Res 2000; 5027-30"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2020.79"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201302827"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4161\/cc.25405"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3580"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00324"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-021-00842-1"},{"key":"B75","unstructured":"Qi G, Zhang C, Ma H. CDCA8, targeted by MYBL2, promotes malignant progression and olaparib insensitivity in ovarian cancer. Am J Cancer Res 2021; 389-415"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2005070"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051372"},{"key":"B78","unstructured":"Robertson KA, Bullock HA, Xu Y. Altered expression of Ape1\/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res 2001; 2220-5"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15092257"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2023.103558"},{"key":"B81","unstructured":"Mo W, Zhang JT. Human ABCG2: structure, function, and its role in multidrug resistance. Int J Biochem Mol Biol 2012; 1-27"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/biology10090849"},{"key":"B83","unstructured":"Chen L, Xu X, Wang J. [Spectrum of gene expression of a multi-drug resistant leukemia cell line with high tumorigenecity in nude mice]. Zhonghua Zhong Liu Za Zhi 2005; 196-200. (in Chinese)"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2020.100742"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02404-3"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42985-3"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147731"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.66.6.1039"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2007.03.005"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2013.03.021"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401103"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.617937"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-576470"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.7.3296"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1021\/bi1007723"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13447"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0700104104"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02158-5"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-54289-6"},{"key":"B100","unstructured":"Hodges LC, Cook JD, Lobenhofer EK. Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells. Mol Cancer Res 2003; 300-11"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1007\/s10735-020-09920-6"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-017-0046-2"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021112"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1186\/2193-1801-2-620"},{"key":"B105","unstructured":"Edwards J, Krishna NS, Witton CJ, Bartlett JMS. Gene amplifications associated with the development of hormone-resistant prostate cancer. Clin Cancer Res 2003; 5271-81"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2544"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgs134"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.7150\/thno.56604"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01641-1"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014618"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-22-1910"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.2174\/1570163812666150602144310"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-021-00721-x"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0306-5"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-91442-8_1"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00849"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01829-8"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.90"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.2165\/11203700-000000000-00000"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116652"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2010.496453"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05180-2"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.00067-16"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m804340200"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/357027"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.21-3-315"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m504703200"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2007.06.002"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-12-28"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.193086"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.23151"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-119944"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.04.027"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-019-03950-y"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108808"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-8049(03)00072-8"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2614"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210204"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0500369102"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2013.09.022"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3747\/co.27.5223"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2016.1149667"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03079-2"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.15.7031"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.84"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.370"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02362-4"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-018-4060-y"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2014.29"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2019.100409"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.08.018"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314891"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2942"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01859"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw287"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.09.022"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2019.1633490"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1097\/cad.0000000000001171"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-21-2433"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-23-1030"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1007\/s10266-017-0326-1"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11764-2"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2016.04.001"},{"key":"B164","unstructured":"Sun B, Wang Y, Sun J. Establishment of patient-derived xenograft models of adenoid cystic carcinoma to assess pre-clinical efficacy of combination therapy of a PI3K inhibitor and retinoic acid. Am J Cancer Res 2021; 773-92"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.07.012"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-015-9333-4"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-795"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0988-2"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-017-0573-6"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.3390\/cells11071162"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100503"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv537"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3136"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.224956"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-021-00421-6"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00655-1"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-020-0194-3"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e11-06-0483"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-022-06434-2"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.170"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1002\/ame2.12282"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-17-2644"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6997"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.012.10263"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080913"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx017"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-13-0442-t"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-15-2301"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111743"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.7"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.497"},{"key":"B192","unstructured":"Thompson MA, Rosenthal MA, Ellis SL. c-Myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression. Cancer Res 1998; 5168-75"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25051"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203176"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024662"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16464"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2012.04.007"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00875-x"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadva.2021.100034"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.9b01071"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2015.04.011"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.03.054"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.201483"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1002\/path.6209"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-022-00538-2"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180939"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-00957-7"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105366"},{"key":"B209","unstructured":"Kasukabe T, Okabe-Kado J, Hozumi M, Honma Y. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes. Cancer Res 1994; 592-7"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.7754\/clin.lab.2018.181008"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-066361"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101931"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-009-0003-2"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/104850"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1038\/onc.205.174"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14950"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101427"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.652"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(91)90021-5"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2017.10.010"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.7150\/jca.53689"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-10-3244"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.498"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04196-2"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.952180"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27072077"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063231"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-668632"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01554-9"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1126354"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2020.01.039"},{"key":"B232","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2017.4116"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(96)00098-6"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.09.001"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.08.131"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31620-1"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010043"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.2c00403"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2022.90"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-14-0662"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02618-6"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.1c04432"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.07.010"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.317"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01701-x"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.ra119.010144"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.952250"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17050"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01262"},{"key":"B250","unstructured":"Sumitani K, Kamijo R, Nagumo M. Cytotoxic effect of sodium nitroprusside on cancer cells: involvement of apoptosis and suppression of c-myc and c-myb proto-oncogene expression. Anticancer Res 1997; 865-71"},{"key":"B251","doi-asserted-by":"crossref","unstructured":"Magrinat G, Mason SN, Shami PJ, Weinberg JB. Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood 1992; 1880-4","DOI":"10.1182\/blood.V80.8.1880.bloodjournal8081880"}],"container-title":["Cancer Drug Resistance"],"original-title":[],"link":[{"URL":"https:\/\/www.oaepublish.com\/articles\/cdr.2023.158","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.oaepublish.com\/articles\/cdr.2023.158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T05:25:13Z","timestamp":1714454713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oaepublish.com\/articles\/cdr.2023.158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":251,"alternative-id":["15"],"URL":"https:\/\/doi.org\/10.20517\/cdr.2023.158","relation":{},"ISSN":["2578-532X"],"issn-type":[{"value":"2578-532X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,30]]}}}